No, clinical-stage biotechnology and pharmaceutical companies like Compass Therapeutics and Compass Pathways do not pay dividends. They reinvest all available capital into research and development, clinical trials, and regulatory advancement pipelines rather than returning cash to shareholders via income distributions.